Thyrocare Technologies Share Price
Start SIP in Thyrocare Technologies
Start SIPThyrocare Technologies Performance
Day Range
- Low 844
- High 862
52 Week Range
- Low 507
- High 931
- Open Price856
- Previous Close862
- Volume22935
Thyrocare Technologies Investment Rating
-
Master Rating:
-
Thyrocare Technologies has an operating revenue of Rs. 593.90 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 17% is great, ROE of 13% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 28% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 19% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 27 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 144 | 141 | 123 | 136 | 124 | 125 |
| Operating Expenses Qtr Cr | 101 | 108 | 92 | 100 | 90 | 102 |
| Operating Profit Qtr Cr | 42 | 34 | 31 | 37 | 33 | 23 |
| Depreciation Qtr Cr | 9 | 10 | 11 | 9 | 9 | 9 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 10 | 6 | 6 | 8 | 8 | 5 |
| Net Profit Qtr Cr | 25 | 19 | 15 | 20 | 17 | 10 |
Thyrocare Technologies Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹856.73
- 50 Day
- ₹808.56
- 100 Day
- ₹749.13
- 200 Day
- ₹690.77
- 20 Day
- ₹870.60
- 50 Day
- ₹799.08
- 100 Day
- ₹716.25
- 200 Day
- ₹672.27
Thyrocare Technologies Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 864.20 |
| Second Resistance | 872.35 |
| Third Resistance | 882.35 |
| RSI | 53.39 |
| MFI | 35.66 |
| MACD Single Line | 19.44 |
| MACD | 12.91 |
| Support | |
|---|---|
| First Support | 846.05 |
| Second Support | 836.05 |
| Third Supoort | 827.90 |
Thyrocare Technologies Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 24,517 | 1,214,082 | 49.52 |
| Week | 51,526 | 2,495,919 | 48.44 |
| 1 Month | 102,386 | 5,386,506 | 52.61 |
| 6 Month | 151,245 | 7,070,716 | 46.75 |
Thyrocare Technologies Result Highlights
Thyrocare Technologies Synopsis
NSE-Medical-Services
Thyrocare Tech. is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 524.02 Cr. and Equity Capital is Rs. 52.95 Cr. for the Year ended 31/03/2024. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.| Market Cap | 4,567 |
| Sales | 544 |
| Shares in Float | 1.54 |
| No of funds | 50 |
| Yield | 2.09 |
| Book Value | 8.89 |
| U/D Vol ratio | 2.9 |
| LTDebt / Equity | 2 |
| Alpha | 0.09 |
| Beta | 0.72 |
Thyrocare Technologies Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 71.11% | 71.11% | 71.11% | 71.14% |
| Mutual Funds | 12.84% | 12.94% | 12.47% | 11.91% |
| Insurance Companies | 1.08% | 1.08% | 1.08% | 1.08% |
| Foreign Portfolio Investors | 2.49% | 2.9% | 3.35% | 3.46% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 8.66% | 8.48% | 9.14% | 9.66% |
| Others | 3.82% | 3.49% | 2.85% | 2.75% |
Thyrocare Technologies Management
| Name | Designation |
|---|---|
| Mr. Rahul Guha | Managing Director & CEO |
| Mr. Dharmil Sheth | Non Executive Director |
| Mr. Hardik Dedhia | Non Executive Director |
| Mr. Dhaval Shah | Non Executive Director |
| Mr. Gopalkrishna Shivram Hegde | Independent Director |
| Dr. Indumati Gopinathan | Independent Director |
| Dr. Neetin S Desai | Independent Director |
| Dr. Prapti Gilada | Independent Director |
| Dr. Harshil Vora | Independent Director |
| Mr. Nishant A Shah | Independent Director |
| Mr. Anandh Sundar | Independent Director |
Thyrocare Technologies Forecast
Price Estimates
Thyrocare Technologies Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-23 | Quarterly Results | |
| 2024-05-14 | Audited Results & Final Dividend | |
| 2024-02-01 | Quarterly Results | |
| 2023-10-31 | Quarterly Results | |
| 2023-08-01 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-16 | FINAL | Rs.18.00 per share(180%)Final Dividend |
| 2023-04-20 | INTERIM | Rs.18.00 per share(180%)Interim Dividend |
| 2022-05-12 | FINAL | Rs.15.00 per share(150%)Interim Dividend |
Thyrocare Technologies FAQs
What is Share Price of Thyrocare Technologies ?
Thyrocare Technologies share price is ₹856 As on 18 September, 2024 | 02:23
What is the Market Cap of Thyrocare Technologies ?
The Market Cap of Thyrocare Technologies is ₹4533 Cr As on 18 September, 2024 | 02:23
What is the P/E ratio of Thyrocare Technologies ?
The P/E ratio of Thyrocare Technologies is 58.4 As on 18 September, 2024 | 02:23
What is the PB ratio of Thyrocare Technologies ?
The PB ratio of Thyrocare Technologies is 8.6 As on 18 September, 2024 | 02:23